Long-term follow-up of a randomized prospective trial comparing a standard 81mg dose of intravesical bacille calmette-guérin with a reduced dose of 27mg in superficial bladder cancer.: BJU Int 2002;89:671–680.

✍ Scribed by J.A Martinez-Pineiro; N Flores; S Isorna; E Solsona; J.L Sebastián; C Pertusa; L.A Rioja; L Martinez-Pineiro; R Vela; J.E Camacho; J.L Nogueira; I Pereira; L Resel; P Muntanola; F Galvis; N Chesa; J.A De Torres; J Carballido; C Bernuy; S Arribas; R Madero

• Book ID: 117724252
• Publisher: Elsevier Science
• Year: 2003
• Tongue: English
• Weight: 22 KB
• Volume: 21
• Category: Article
• ISSN: 1078-1439
• DOI: 10.1016/s1078-1439(02)00289-2